UNC Health

System Formulary Restriction:

Inpatient use of obinutuzumab injection is limited to a one-time dose and is restricted to patients who meet the following criteria:

• Relapsed/Refractory B-cell lymphoma(s) AND
• Require urgent inpatient initiation of glofitamab treatment with
  obinutuzumab pretreatment and administration of obinutuzumab cannot
  be deferred to the outpatient setting due to patient clinical status OR
• Active class III-V lupus nephritis where administration of obinutuzumab
  cannot be deferred to the outpatient environment

All other use is restricted to outpatient encounters or clinic use only (i.e., no inpatient use)

Med Center
     UNC Medical Center Formulary Restrictions

Rex
     Rex Hematology-Oncology Formulary Restrictions

• Lexicomp
• Micromedex
• UpToDate
• FDA Daily Med